Picton Mahoney Asset Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Picton Mahoney Asset Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$4K	–	580
2023 Q1	$4K	Hold	100,000	–	–	﹤0.01%	472
2022 Q4	$1K	Hold	100,000	–	–	﹤0.01%	665
2022 Q3	$9K	Hold	100,000	–	–	﹤0.01%	648
2022 Q2	$12K	Hold	100,000	–	–	﹤0.01%	747
2022 Q1	$29K	Buy	+100,000	New	+$36.5K	﹤0.01%	780

Picton Mahoney Asset Management's IQMDW Position: Q2 2023 in Review

Picton Mahoney Asset Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 100,000 shares — an estimated $4K sold.

Picton Mahoney Asset Management first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $29K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Picton Mahoney Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 100,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $4K.
Picton Mahoney Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
Picton Mahoney Asset Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $29K in Q1 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.